NCT02148432View on ClinicalTrials.gov

Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 19, 2014

Primary Completion Date

April 29, 2016

Study Completion Date

April 29, 2016

Conditions
Sleep Apnea Syndrome
Interventions
DRUG

dexmedetomidine infusion rate, 0.5 mcg/kg/hr

continuous infusion of dexmedetomidine at rate of 0.5 mcg/kg/hr

DRUG

dexmedetomidine infusion rate, 1.0 mcg/kg/hr

continuous infusion of dexmedetomidine at rate of 1.0 mcg/kg/hr

Trial Locations (1)

120-752

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02148432 - Establishment of Ideal IV Sedative Regimen for Successful Fiberoptic Bronchoscopy in Assessing the Site, Severity of Sleep Apnea Syndrome | Biotech Hunter | Biotech Hunter